- Report
- April 2025
- 89 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 385 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 89 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 222 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 214 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 193 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 246 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 197 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 192 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 220 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 279 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 387 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 379 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 284 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 553 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 170 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 480 Pages
Global
From €5324EUR$5,850USD£4,522GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more